Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.

3.0.0 97 2022-11-15T16:33:08Z 2022-11-15T16:33:08Z Senate S SRES 2013-04-15 113 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2013-04-15T22:28:39Z Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs. 113 161 HRES 2013-04-19 Referred to the Subcommittee on Health. Related bill CRS 2013-04-15 sshr00 Health, Education, Labor, and Pensions Committee Senate Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2654) IntroReferral 2013-04-15 Introduced in Senate IntroReferral 10000 9 Library of Congress C000560 Sen. Coburn, Tom [R-OK] TOM COBURN R OK N S000148 Sen. Schumer, Charles E. [D-NY] Charles Schumer D NY E. 2013-04-15 True M000355 Sen. McConnell, Mitch [R-KY] Mitch McConnell R KY 2013-04-15 True A000360 Sen. Alexander, Lamar [R-TN] Lamar Alexander R TN 2013-04-16 False Health Drug safety, medical device, and laboratory regulation Drug, alcohol, tobacco use Prescription drugs Health

00 2013-04-15 Introduced in Senate 2013-05-16T15:24:03Z Expresses the sense of the Senate that the Food and Drug Administration (FDA) should exercise its acknowledged authority to: (1) refuse to approve generic versions of non-abuse-deterrent opioid products that have been replaced in the market with abuse-deterrent formulations recognized by FDA as effective, and (2) require generic versions of abuse-deterrent opioid products to be formulated with comparable abuse-deterrent features.

]]>

A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs. Display Title A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs. Official Title as Introduced A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs. Introduced in Senate 2013-04-15T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113sres97is/xml/BILLS-113sres97is.xml 2013-04-15 Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2654) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.